NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Prism VentureWorks’

19 May 2014

US biopharma Proteon Therapeutics raises $45m Series D

US biopharmaceutical company Proteon Therapeutics has closed a $45m of Series D equity financing, including a $25m tranche to fully fund the first Phase 3 clinical study of its lead product.

3 December 2013

Xlumena venture backers re-up commitments through $25m Series C round

Xlumena Venture capital-backed medical device maker Xlumena has picked up another $25m of funding through a Series C round led by Third Point.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014